Peristomal Localized Pemphigoid: Is It an Underdiagnosed Condition with a Good Prognosis?

Can Baykal1, Elizaveta Melnicova Ayas, Tuğba Atcı

  • 1Can Baykal, MD, is Professor, Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Elizaveta Melnicova Ayas, MD, is Resident; Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Tuğba Atcı, MD, is Assistant Professor; Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Şule Öztürk Sarı, MD, is Associate Professor, Department of Pathology; Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; and Nesimi Büyükbabani, MD, is Professor, Department of Pathology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey and Koç Medical Faculty, Istanbul,; and Rıfkiye Küçükoğlu, MD, is Professor, Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

PubMed
Summary

Peristomal bullous pemphigoid (BP) involvement is rare, affecting 1.5% of patients. Early recognition of these lesions is crucial for accurate diagnosis and favorable outcomes, differentiating it from irritant dermatosis.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
75
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
333
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
114